Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

Rather than working on the surface of cells like some cancer medicines, small molecules are able to slip inside the cell to ...

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the European ...

Scientists have found a key weakness in prostate cancer cells. Two enzymes, PDIA1 and PDIA5, help cancer cells survive and ...

Health officials from across the country met today in Des Moines to address the significant surge in cancer cases in Iowa.

To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. Staying fit can make ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

Former President Joe Biden is receiving radiation and hormone therapy to the treat aggressive form of prostate cancer he was ...